Speaker Series – Unravelling Biosimilars

This review is a summary of a recent talk at the ARA annual meeting on unravelling biosimilars.
The presentations focused primarily on the development and manufacture of biologic disease-modifying antirheumatic drugs (DMARDs); insight into potential clinical challenges with biosimilar introduction; and a perspective on biosimilars from a patient support group.

Please login below to download this issue (PDF)

Subscribe